UK Backs Dementia Diagnostics With Up to £80 Million Innovation Programme
A staged UK programme will test nine dementia diagnostic technologies in the NHS, linking funding to evidence and targeting deployment from 2029.
Health & Wellness
Latest Posts
Sunway Medical Centre Damansara Launch Sharpens Private Healthcare Focus
Sunway Medical Centre Damansara’s official launch highlights its Selangor growth plans, while current operating capacity still needs clear disclosure.
Health Ministry Sets 7 October Reporting Deadline for Newly Appointed Doctors
Malaysia’s Health Ministry has set 7 October for newly appointed medical officers to report, while cautioning against premature conclusions on deployment.
MediAsas Sets a 2027 Test for Affordable Health Cover in Malaysia
MediAsas promises standardised basic medical cover, but final pricing, exclusions and claim performance will determine its value for Malaysian households.
Optimax’s Nasenmax Launch Tests Its Move Beyond Eye Care
Optimax has opened its first Nasenmax ENT clinic in Selangor, but has not disclosed patient targets, investment cost or the new service’s earnings outlook.
WHO Leadership Race Reaches Five Prospective Candidates, Including Indonesia’s Health Minister
The WHO lists five prospective candidates for its next director-general, including Indonesia’s Budi Gunadi Sadikin, with selection stages continuing into 2027.
FDA Nominee’s Senate Hearing Puts US Drug Regulation and Vaccine Policy on Watch
Heidi Overton’s Senate hearing brought vaccine policy and regulatory independence into focus as investors assess the future of US drug oversight.
Malaysia’s Private Hospitals Seek Budget 2027 Funding for Health Oversight
Private hospitals seek stronger Budget 2027 support for medical oversight, healthcare travel and accreditation, with funding decisions still pending.
US Ebola Funding Pledge Adds Resources as Central Africa Response Intensifies
A new US$267 million commitment aims to strengthen Ebola treatment and testing in central Africa, with delivery still to be monitored.
AstraZeneca–MSN Partnership Puts Rare-Disease Recognition and Care Coordination in Focus
A two-year collaboration will explore non-promotional education and care-pathway initiatives, with implementation central to its patient-focused aims.